- Home
- RPRX vs WPC Comparison
RPRX vs WPC Comparison
Compare RPRX & WPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- WPC
- Stock Information
- Founded
- RPRX 1996
- WPC 1973
- Country
- RPRX United States
- WPC United States
- Employees
- RPRX N/A
- WPC N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- WPC Real Estate Investment Trusts
- Sector
- RPRX Health Care
- WPC Real Estate
- Exchange
- RPRX Nasdaq
- WPC Nasdaq
- Market Cap
- RPRX 15.6B
- WPC 14.7B
- IPO Year
- RPRX 2020
- WPC 1998
- Fundamental
- Price
- RPRX $35.15
- WPC $68.65
- Analyst Decision
- RPRX Strong Buy
- WPC Hold
- Analyst Count
- RPRX 3
- WPC 11
- Target Price
- RPRX $45.33
- WPC $101.20
- AVG Volume (30 Days)
- RPRX 3.9M
- WPC 1.1M
- Earning Date
- RPRX 11-05-2025
- WPC 10-28-2025
- Dividend Yield
- RPRX 2.50%
- WPC 5.24%
- EPS Growth
- RPRX 54.86
- WPC N/A
- EPS
- RPRX 2.32
- WPC 1.52
- Revenue
- RPRX $2,305,243,000.00
- WPC $1,636,111,000.00
- Revenue This Year
- RPRX $33.77
- WPC $7.46
- Revenue Next Year
- RPRX $4.62
- WPC $3.36
- P/E Ratio
- RPRX $15.12
- WPC $45.15
- Revenue Growth
- RPRX 3.02
- WPC N/A
- 52 Week Low
- RPRX $24.05
- WPC $52.91
- 52 Week High
- RPRX $38.00
- WPC $69.00
- Technical
- Relative Strength Index (RSI)
- RPRX 40.78
- WPC 64.95
- Support Level
- RPRX $35.97
- WPC $66.97
- Resistance Level
- RPRX $36.94
- WPC $68.28
- Average True Range (ATR)
- RPRX 0.85
- WPC 0.87
- MACD
- RPRX -0.06
- WPC 0.12
- Stochastic Oscillator
- RPRX 33.46
- WPC 89.99
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About WPC W. P. Carey Inc. REIT
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.